Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Imfinzi + Imjudo recommended for approvals in EU

Investegate announcements from AstraZeneca PLC, Imfinzi + Imjudo recommended for approvals in EU

Related Keywords

Canada ,Japan ,United States ,United Kingdom ,China ,South Africa ,Cambridge ,Cambridgeshire ,Switzerland ,America ,Astrazeneca Imfinzi ,Daiichi Sankyo ,Bruno Sangro ,Imfinziplus Imjudo ,Susan Galbraith ,Hospitalier Universitaire Vaudois ,Imjudoand Imfinzi ,Solange Peters ,University Of Navarra School Medicine ,European Society For Medical Oncology Congress ,Lung Ambition Alliance ,Nasdaq ,Merck Co Inc ,Astrazeneca ,Investor Relations Team ,European Union ,European Medicines Agency ,Committee For Medicinal Products Human Use ,European Society For Medical Oncology ,Medicinal Products ,Human Use ,New England Journal ,Medicine Evidence ,Liver Unit ,Universidad De Navarra ,Internal Medicine ,Navarra School ,European Society ,Medical Oncology ,Executive Vice President ,Medical Oncology Congress ,South America ,Rare Diseases ,View All ,Accessed November ,Investegate Announcements ,Investegate Company Announcements ,Astrazeneca Plc ,Egulatory News Service ,Egulatory News Service And Regulatory ,Ns ,